Stress and skin: the HPA axis, cortisol, and how psychological stress triggers flares
A complete guide to the stress-skin connection — the HPA axis cortisol pathway and its effects on sebum production, barrier function, and inflammation, how psychological stress triggers acne, eczema, rosacea, and psoriasis flares through specific immune mechanisms, the neuropeptide substance P pathway in skin, and evidence-based interventions.
· By MedSpot Editorial · 6 min read
The observation that skin conditions worsen during periods of psychological stress is so consistent across conditions and patients that it functions as a clinical axiom. But the relationship is not merely anecdotal — it operates through specific, well-characterized neuroimmune pathways that connect the brain to the skin. Understanding these mechanisms explains both the phenomenon and why stress management is a genuine therapeutic component of skin condition management.
The HPA axis: stress hormones and the skin
The cortisol pathway
Psychological or physiological stress activates the hypothalamic-pituitary-adrenal (HPA) axis:
- Hypothalamus releases CRH (corticotropin-releasing hormone)
- Anterior pituitary releases ACTH (adrenocorticotropic hormone)
- Adrenal cortex releases cortisol
Cortisol then acts on virtually every organ system — including the skin, which expresses glucocorticoid receptors throughout the epidermis and dermis.
Cortisol effects on skin:
Sebaceous glands: Cortisol stimulates CRH receptor expression in the sebaceous gland → increased sebum production. Additionally, cortisol elevates androgen activity (by reducing sex hormone binding globulin levels) → amplified androgenic drive on sebaceous glands → further sebum increase.
Barrier function: Cortisol directly inhibits ceramide synthesis and filaggrin expression in keratinocytes → impaired stratum corneum lipid matrix → increased TEWL → compromised barrier. This creates a mechanistic link between chronic stress and chronically reactive, dry, barrier-compromised skin.
Collagen: Glucocorticoids suppress procollagen I and III gene expression in fibroblasts and upregulate MMP-1 (collagenase) → net collagen deficit with chronic stress exposure.
Immune dysregulation: Acute cortisol elevation is anti-inflammatory (suppressing NFκB and pro-inflammatory cytokine production). However, with chronic stress, glucocorticoid receptors in immune cells undergo desensitization (glucocorticoid resistance) → the initially anti-inflammatory effect wanes and the skin and systemic immune system paradoxically become more inflammatory.
The CRH-mast cell axis
CRH is not only produced centrally — skin cells (keratinocytes, mast cells, sebaceous gland cells) produce CRH locally in response to stress signals. Cutaneous CRH acts on:
- Mast cells: CRH directly degranulates mast cells → histamine, tryptase, prostaglandins → neurogenic inflammation in the skin → redness, itching, and barrier disruption without requiring systemic cortisol elevation
- Sebaceous glands: Cutaneous CRH drives sebum production independently of the systemic HPA axis
This local CRH-mast cell pathway is particularly relevant for stress-triggered urticaria, rosacea flushing, and the immediate skin responses to acute stress that occur faster than systemic cortisol could account for.
Substance P: the neuropeptide-skin connection
Substance P (SP) is a neuropeptide released from sensory nerve endings in the skin during stress. Sensory nerves are abundant in the skin and directly communicate with immune cells through neuropeptide signaling:
Substance P effects:
- Directly degranulates mast cells → neurogenic inflammation
- Activates keratinocytes → IL-1β, TNF-α, IL-8 production
- Promotes T-cell recruitment and activation in the dermis
- Increases sebaceous gland activity
- Drives the itch-scratch cycle in atopic dermatitis through TRPV1 sensitization
Clinical relevance: Elevated substance P in skin has been documented in atopic dermatitis, rosacea, acne, and psoriasis lesional skin. SP is the direct molecular link between psychological stress (which activates sensory nerves via the central nervous system) and skin inflammation.
Stress and specific skin conditions
Acne
The stress-acne mechanism:
- CRH (local cutaneous) + cortisol (systemic) → sebum overproduction
- Cortisol → androgen receptor sensitization → amplified androgenic sebum drive
- Substance P → mast cell activation → pro-inflammatory cytokines → comedone conversion to inflammatory papule
Evidence: Chiu et al. (2003, Archives of Dermatology): study of 22 university students; acne severity correlated significantly with academic stress levels during exam periods vs. lower-stress periods. Sebum production was not elevated, suggesting the stress effect operates through inflammatory conversion of existing comedones rather than increasing total sebum output.
Clinical implication: Stress management is a genuine adjunct in acne management — particularly for patients who notice consistent stress-related flares.
Atopic dermatitis
The stress-AD mechanism:
- Cortisol-impaired barrier → increased allergen and irritant penetration → inflammatory trigger
- Cortisol-suppressed ceramide synthesis → amplified existing barrier deficit in AD
- CRH/SP → mast cell degranulation → pruritus → scratch → barrier damage → further penetration
- Psychological stress activates the same Th2 cytokine cascade (IL-4, IL-13) that drives AD, via HPA-mediated immune dysregulation
Evidence: Multiple studies document exacerbation of AD severity during examination periods, bereavement, and other psychological stressors. Buske-Kirschbaum et al. (1997, Psychosomatic Medicine): AD patients show blunted HPA axis cortisol response to stress AND exaggerated skin inflammatory response — the stress regulation system and the skin inflammatory system are both dysfunctional simultaneously.
Psoriasis
Psoriasis is particularly stress-sensitive: 30–88% of psoriasis patients report stress as a trigger for flares. The Koebner phenomenon (new psoriatic plaques developing in areas of skin trauma) has a neuroimmune analogue — psychological stress generates substance P release → mast cell activation → dendritic cell activation → Th17 IL-17A production → psoriatic cascade.
The vicious cycle: Psoriasis → psychological distress (from visible, stigmatized disease) → stress → psoriasis flare → more distress. This bidirectional reinforcement is mechanistically established and clinically significant — psychiatric comorbidity (depression, anxiety) in psoriasis patients is substantially higher than in the general population, and treating depression in psoriasis patients improves skin disease severity in some studies.
Rosacea
The CRH-mast cell axis and SP-mediated neurogenic inflammation are highly relevant in rosacea:
- Acute psychological stress → CRH → mast cell degranulation → vasoactive mediators → flushing episode
- Chronic stress → sustained neurogenic inflammation → rosacea progression from episodic flushing to persistent erythema and papulopustular disease
Rosacea patients consistently list stress as among the most common and severe triggers — second only to UV exposure and heat.
Evidence-based interventions
Mindfulness-based stress reduction (MBSR)
Kabat-Zinn et al. (1998, Psychosomatic Medicine): The landmark study that established psychological intervention in dermatology. Psoriasis patients undergoing phototherapy were randomized to phototherapy alone vs. phototherapy + mindfulness meditation audio guidance. The meditation group achieved PASI clearance at 3.8× the rate of the control group at the same UV dose.
Mechanism: Mindfulness reduces HPA axis reactivity → lower cortisol → reduced immunosuppression resistance → enhanced response to UV therapy. A mechanistically coherent result.
MBSR and mindfulness-based cognitive therapy (MBCT) have also shown benefit in AD severity (multiple RCTs) and quality of life in psoriasis patients.
Psychological therapy for itch-scratch cycles
In atopic dermatitis, the itch-scratch cycle is partly psychologically conditioned — scratch becomes a habituated response to stress, anxiety, or even mild sensory input. Habit reversal training (HRT) — a behavioral technique in which scratching is replaced with an incompatible competing behavior — significantly reduces scratch events and secondary barrier damage in multiple RCTs.
Sleep (see Sleep and Skin guide)
The sleep-stress axis is bidirectional: stress impairs sleep; sleep deprivation elevates cortisol. Addressing sleep is one of the most effective strategies for breaking the stress-cortisol-skin cycle.
Exercise
Regular aerobic exercise reduces baseline HPA axis reactivity → lower cortisol response to acute stressors. Exercise also increases cerebral serotonin and BDNF → reduced anxiety and depression → reduced stress-driven skin flares. Post-exercise hygiene matters (see Body Acne guide) — sweat + friction + heat during exercise can trigger follicular conditions independently.
What stress management cannot do
Stress management reduces flare frequency and severity — it does not address the underlying pathophysiology of inflammatory skin conditions. A patient with moderate-to-severe psoriasis or atopic dermatitis requires appropriate topical or systemic medical treatment; stress management is an adjunct, not a substitute.
Avoid the tendency to attribute skin conditions primarily to stress ("just relax and it'll clear up") — this dismisses the biological complexity of these conditions and the inadequacy of stress alone as an explanation for their severity.
Looking for a dermatology or skincare consultation? Browse med spa providers on MedSpot →